Ticker Sage

Form 4 · LLY

Eli Lilly director Katherine Baicker reports an award of about 168 shares

Part of a grouped insider digest: see all related filings with totals →

Katherine Baicker, an Eli Lilly director, filed a Form 4 on Nov 17, 2026 at 4:14 PM ET reporting transactions on Nov 16, 2026.

The filing reports about 168 shares in a grant or award (code A).

After these transactions, the filing lists about 23,815 shares held directly.

Effect on holdings

Taken together, the rows reported here raised Katherine Baicker's directly held shares by 0.7%, from about 23,648 to about 23,815.

Reporting person

Transactions as reported

DateCodeSecuritySharesPriceAcquired or disposedHeld afterOwnership
2026-11-16ACommon Stock168$1,431.67Acquired23,815Direct

Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.

Source

Eli Lilly company file → · More Eli Lilly filings

Disclosures

Editor holdings in LLY
The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
Last updated
Nov 17, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.